Found: 8
Select item for more details and to access through your institution.
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1153, doi. 10.1007/s00262-011-1026-2
- By:
- Publication type:
- Article
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52000-3
- By:
- Publication type:
- Article
High Frequency of Germline <i>TP53</i> Mutations in a Prospective Adult-Onset Sarcoma Cohort.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069026
- By:
- Publication type:
- Article
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 10, p. 3087, doi. 10.1172/JCI30605
- By:
- Publication type:
- Article
A universal molecular control for DNA, mRNA and protein expression.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46456-9
- By:
- Publication type:
- Article
Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 6, p. 1823, doi. 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B
- By:
- Publication type:
- Article
A quantitative model to predict pathogenicity of missense variants in the TP53 gene.
- Published in:
- Human Mutation, 2019, v. 40, n. 6, p. 788, doi. 10.1002/humu.23739
- By:
- Publication type:
- Article
Stress-induced cellular adaptive strategies: Ancient evolutionarily conserved programs as new anticancer therapeutic targets.
- Published in:
- BioEssays, 2014, v. 36, n. 6, p. 552, doi. 10.1002/bies.201300170
- By:
- Publication type:
- Article